Search bioRxiv⌕ Search

Biology subjects

Reyes-Lamothe, R.

Publications and source records attributed to Reyes-Lamothe, R..

3 recordsLinked to original sources

Cell Size Modulates SBF and Whi5 Chromatin Binding to Regulate the Start of the Budding Yeast Cell Cycle

Cell growth and division are tightly coordinated to cell size. In budding yeast, increasing cell size promotes the G1/S transition, called Start, by activating the transcription factor SBF, which drives a large fraction of cell-cycle-dependent gene expression. Part of this regulation arises because the concentration of the SBF inhibitor Whi5 decreases as cells grow. However, cells lacking Whi5 can still maintain a relatively accurate size when the SBF activator Cln3 is also removed, indicating that there are additional size control mechanisms. To understand how cell size is mechanistically translated into the activity of SBF-regulated promoters, we quantified the binding kinetics of Whi5 and SBF in live cells using single-molecule fluorescence microscopy. We found that increasing cell size is associated with both a decreased chromatin affinity of Whi5 and an increased chromatin affinity of SBF, accompanied by a higher SBF:Whi5 cell copy-number ratio. Chromatin-binding trends under basal and Whi5 overexpression conditions indicate that Whi5 restricts SBF association with chromatin. The transition point at which SBF binding overtakes Whi5 binding coincides with the onset of the expression of the G1 cyclins CLN1 and CLN2, two SBF targets that are important for committing cells to division. Reduced Whi5 binding reflects changes in its chromatin-association rate, as Whi5 and SBF dwell times on chromatin remain [~]10 s and are largely independent of cell size. Together, these results show how changes in SBF and Whi5 abundance and chromatin association transmit cell size information to the genome to regulate the size-dependent Start transition in budding yeast.

cell biology↗

The Rtf1/Prf1-dependent histone modification axis and Rpb1 C-terminal domain phosphorylation counteract multi-drug resistance in fission yeast

AbstractRNA polymerase II (RNAPII) transcription elongation directs an intricate pattern of histone modifications. Formation of this pattern involves a highly conserved regulatory axis, key components of which are the elongation factor Rtf1, monoubiquitylation of histone H2B (H2Bub1), and methylation of histone H3 on lysine 4 (H3K4me). Direct contact between Rtf1 and the ubiquitylation complex Rad6-Bre1 stimulates H2Bub1, which in turn promotes H3K4me by stimulating the activity of the Set1C/COMPASS methyltransferase complex. Previous studies have defined the molecular basis for these regulatory relationships, but it remains unclear how they regulate chromatin and transcription in vivo. We found that mutations affecting multiple components of the Rtf1-H2Bub1-H3K4me axis in the model eukaryote Schizosaccharomyces pombe (fission yeast) caused resistance to the ribonucleotide reductase inhibitor hydroxyurea (HU). Resistance correlated with a reduced effect of HU on dNTP pools, bypass of the S-phase checkpoint in the presence of HU, and blunting of the transcriptional response to HU treatment. Mutations in the C-terminal repeat domain (CTD) of the RNAPII large subunit Rpb1 led to a similar spectrum of phenotypes. Moreover, all the HU resistant mutants we identified also exhibited resistance to several azole class antifungal agents. Our results suggest a novel, shared gene regulatory function of the Rtf1-H2Bub1-H3K4me axis and the Rpb1 CTD in controlling fungal drug tolerance.

molecular biology↗

RNA polymerase II dynamics and mRNA stability feedback determine mRNA scaling with cell size

A fundamental feature of cellular growth is that protein and RNA amounts scale with cell size so that concentrations remain constant. A key component to this is that global transcription rates increase in larger cells, but the underlying mechanism has remained unknown. Here, we identify RNAPII as the major limiting factor increasing transcription with cell size in budding yeast as transcription is highly sensitive to the dosage of RNAPII but not to other components of the general transcriptional machinery. Our experiments support a dynamic equilibrium model where global transcription at a given size is set by the mass-action recruitment kinetics of unengaged nucleoplasmic RNAPII, and DNA content. This drives a sub-linear increase in transcription with size, which is precisely compensated for by a decrease in mRNA decay rates as cells enlarge. Thus, limiting RNAPII and feedback on mRNA stability work in concert to ensure mRNA concentration homeostasis in growing cells.

molecular biology↗